BXP vs Howard Hughes
BXP and HHH side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BXP and HHH compare
BXP is the larger company, worth 2.0 times as much as Howard Hughes ($10.1B against $5.0B).
On earnings, Howard Hughes is cheaper: it trades at 33.1× trailing earnings, against 34.1× for BXP.
Howard Hughes grew revenue faster over the last twelve months (42.8% versus 1.9% for BXP).
BXP keeps more of each dollar of sales as profit, with a net margin of 8.4% compared with 6.5% at Howard Hughes.
BXP pays a dividend yielding 4.4%; Howard Hughes does not pay one.
BXP scores higher on the StockData Score (7 against 6 for Howard Hughes), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BXP | HHH |
|---|---|---|
| Size and price | ||
| Market cap | $10.1B | $5.0B |
| Share price | $63.44 | $83.85 |
| Change, 1 year | −11.4% | −5.9% |
| Change, 5 years | −45.8% | −4.3% |
| Beta (5Y) | 0.98 | 1.08 |
| Employees | 714 | 500 |
| StockData Score | ||
| Total score | 7 (better) | 6 |
| Valuation score | 0 | 2 (better) |
| Growth score | 1 | 1 |
| Performance score | 1 | 3 (better) |
| Health score | 2 (better) | 0 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 34.1× | 33.1× (better) |
| P/S | 2.9× | 1.9× (better) |
| P/B | 2.0× | 1.3× (better) |
| EV/EBITDA | – | 3.3× |
| Fair value | $60.66 | $85.36 |
| Margin of safety | −4.6% | 1.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 1.9% | 42.8% (better) |
| Revenue growth, 5Y average | 4.7% | – |
| Net income growth (TTM) | 5922% (better) | −37.5% |
| EPS growth (TTM) | 4550% (better) | −50.7% |
| EPS growth, 5Y average | −20.7% | – |
| Profitability | ||
| Gross margin | 59.1% | – |
| Operating margin | – | 18.1% |
| Net margin | 8.4% (better) | 6.5% |
| Return on equity | 5.7% (better) | 4.4% |
| Return on invested capital | – | 21.3% |
| Financial health | ||
| Debt / equity | 0.15 | – |
| Interest coverage | – | 2.6× |
| Altman Z-score | 0.39 | 0.53 (better) |
| Piotroski F-score | 6 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 4.4% | – |
| Payout ratio | 184% | – |
| Shareholder yield | 4.4% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 117% | 90.6% |
| Held by insiders | 0.21% | 94.9% |
| Insider net buying, 12 months | −$5.2M | $1.0M (better) |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 8.0% | 182% |
Go deeper
- BXP stock overview
- BXP income statement
- BXP valuation and score
- HHH stock overview
- HHH income statement
- HHH valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.